Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: a comparison with MDMA. (Q52170975)

26 April 2018

MDMA

0 references

title

Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: a comparison with MDMA. (English)

1 reference

26 April 2018

author name string

M Barrionuevo

1

1 reference

26 April 2018

N Aguirre

2

1 reference

26 April 2018

J D Del Río

3

1 reference

26 April 2018

B Lasheras

4

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 February 2000

1 reference

26 April 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

26 April 2018

volume

65

1 reference

26 April 2018

issue

2

1 reference

26 April 2018

page(s)

233-240

1 reference

26 April 2018

MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Possible serotonergic and dopaminergic mediation of the N-ethyl-3,4-methylenedioxyamphetamine discriminative stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Memory impairment in abstinent MDMA ("Ecstasy") users

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Serotonin receptors in cognitive behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Physiopharmacological interactions between stress hormones and central serotonergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, “Eve”) and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Characterization of [3H]paroxetine binding in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Pathology of deaths associated with "ecstasy" and "eve" misuse

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Memory deficits associated with recreational use of "ecstasy" (MDMA).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Excessive serotonin release, not depletion, leads to memory impairments in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Immunocytochemical evidence for serotonergic neurotoxicity of N-ethyl-methylenedioxyamphetamine (MDE).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve').

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Contrasting effects of systemic and intracerebral infusions of the 5-HT1A receptor agonist 8-OH-DPAT on spatial short-term working memory in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

Contents of "ecstasy"

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900170-7

7 January 2021

10.1016/S0091-3057(99)00170-7

Identifiers

DOI

1 reference

26 April 2018

1 reference

26 April 2018